Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Drops By 83.6%

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 3,556 shares, a decline of 83.6% from the April 30th total of 21,619 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 39,773 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy”.

Nihon Kohden Stock Down 1.7%

Shares of OTCMKTS NHNKY traded down $0.16 during midday trading on Friday, hitting $9.00. The stock had a trading volume of 7,835 shares, compared to its average volume of 27,960. The company has a market capitalization of $1.54 billion, a price-to-earnings ratio of 15.25 and a beta of 0.41. Nihon Kohden has a 1-year low of $8.71 and a 1-year high of $14.21. The company has a fifty day moving average price of $9.39 and a 200 day moving average price of $10.34.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.10. The business had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%. On average, research analysts forecast that Nihon Kohden will post 0.61 EPS for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.